Abstract
Diabetic kidney disease (DKD) is a complication that develops in approximately 40% of patients with type 2 diabetes mellitus (T2DM) and represents one of the main causes of progression to chronic kidney disease (CKD). It is known that inflammation, both systemic and local, plays an important role in the development of DKD. Macrophages are among the main types of immune cells present in ki…